Literature DB >> 3093223

A 168-kilodalton protein of Mycoplasma pneumoniae used as antigen in a dot enzyme-linked immunosorbent assay.

E Jacobs, K Fuchte, W Bredt.   

Abstract

The attachment protein of Mycoplasma pneumoniae (molecular weight 168 kd) was used as antigen in a special enzyme-linked immunosorbent assay (dot ELISA) and compared with a sonicate of the whole organism. In control sera the intensity of the 168-kd band on immunoblots correlated well with the ELISA IgG values derived from isolated protein. The diagnostic significance of the 168-kd antigen was tested on paired sera from 33 patients with Mycoplasma pneumoniae infection (24 children, 9 adults). The ELISA values with the isolated protein were slightly lower than with cell antigen, but the protein also showed a lower basic activity in controls. In first sera of specimens of children collected within the first week of infection the 168-kd IgM response was more distinct than that to the whole cell antigen. Similarly the IgG response to the purified protein antigen differed significantly from the controls already in the first serum. In sera of adult patients the increased levels of IgG antibody were more evident with the 168-kd protein antigen. Use of the protein 168 kd as antigen increased the sensitivity of the ELISA for detecting early stages of disease, especially in children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093223     DOI: 10.1007/bf02075700

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  23 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Immunological relationships between Mycoplasma pneumoniae and Streptococcus MG.

Authors:  K Lind
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Questionable specificity of lipid antigen in the Mycoplasma pneumoniae complement fixation test in patients with extrapulmonary manifestations.

Authors:  A Pönkä; T Pönkä; S Sarna; K Penttinen
Journal:  J Infect       Date:  1981-12       Impact factor: 6.072

5.  Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis.

Authors:  M Kleemola; H Käyhty
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

6.  Mycoplasma pneumoniae adhesin localized to tip structure by monoclonal antibody.

Authors:  J Feldner; U Göbel; W Bredt
Journal:  Nature       Date:  1982-08-19       Impact factor: 49.962

7.  Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  A J van Griethuysen; R de Graaf; J A van Druten; F W Heessen; J T van der Logt; A M van Loon
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

8.  Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis.

Authors:  P O Leinikki; P Panzar; H Tykkä
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

9.  Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay.

Authors:  S M Räisänen; J I Suni; P Leinikki
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

10.  Host discrimination of Mycoplasma pneumoniae proteinaceous immunogens.

Authors:  D K Leith; L B Trevino; J G Tully; L B Senterfit; J B Baseman
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  9 in total

1.  Indirect enzyme-linked immunosorbent assay for detection of immunoglobulin G reactive with a recombinant protein expressed from the gene encoding the 116-kilodalton protein of Mycoplasma pneumoniae.

Authors:  M F Duffy; K G Whithear; A H Noormohammadi; P F Markham; M Catton; J Leydon; G F Browning
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection.

Authors:  Miroslav Harjacek; Jelena Ostojic; Oktavija Djakovic Rode
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

3.  A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; R Röck; L Dalehite
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Rapid immunoblot method for diagnosis of acute Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Thomas; P J Middleton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  Binding sites of attachment-inhibiting monoclonal antibodies and antibodies from patients on peptide fragments of the Mycoplasma pneumoniae adhesin.

Authors:  E Jacobs; B Gerstenecker; B Mader; C H Huang; P C Hu; R Halter; W Bredt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

7.  Characterization of the cellular response of spleen cells in BALB/c mice inoculated with Mycoplasma pneumoniae or the P1 protein.

Authors:  K Pietsch; E Jacobs
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

8.  Immunodominant epitopes of the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; A Pilatschek; B Gerstenecker; K Oberle; W Bredt
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

9.  Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia.

Authors:  Mark T Muir; Stephen M Cohn; Christopher Louden; Thirumalai R Kannan; Joel B Baseman
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.